Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets. - Wikidata - wikimedia - TriplyDB

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

http://www.wikidata.org/entity/Q33693852

about

Pathogenesis of Helicobacter pylori infection Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.A Gnotobiotic Pig Model for Determining Human Norovirus Inactivation by High-Pressure Processing In Vitro and In Vivo Anti-Helicobacter Activities of Eryngium foetidum (Apiaceae), Bidens pilosa (Asteraceae), and Galinsoga ciliata (Asteraceae) against Helicobacter pylori.Treatment of Helicobacter pylori infected mice with Bryophyllum pinnatum, a medicinal plant with antioxidant and antimicrobial properties, reduces bacterial load.Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.

P2860

Q24679810-BD704A31-8942-41DE-BF99-7D732C44F07A Q33976598-B62CB1FF-E7CE-45AB-A1EF-D2E6772F7102 Q34107991-B6C8A303-81F7-47DE-BB3C-8200BF741374 Q36033161-AEA190A5-25A5-42D4-97D7-180FEF975462 Q37222948-B37625B4-8B4F-49E8-97B7-A71A0A5192BA Q39114101-3209A080-9131-4BB6-93EE-7E1387C87F38 Q39475192-386F6F7E-9291-49F2-8386-58A6F0658CDC

P2860

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

http://www.wikidata.org/entity/Q33693852

description

1998 nî lūn-bûn

@nan

1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

name

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@ast

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@en

type

label

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@ast

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@en

prefLabel

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@ast

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@en

P1433

Q33693852-5592DFA8-C087-4492-A4EE-AF398E34322E

P1476

Q33693852-377B6267-CD6A-4D34-90E5-B40DCE7583E9

P2093

Q33693852-22516B76-5759-44A0-8EC3-4BDF0D33D104

Q33693852-4DCBE4CB-2ACD-4E95-BC40-C287278EA3B7

Q33693852-C597D339-9EBD-4699-8B3A-5C60BD166F63

P2860

Q33693852-0988DE7B-FBCB-48B7-A729-E42E2FD259B7

Q33693852-1A848C47-C84C-4167-AB01-40AD94CCA99A

Q33693852-1DCC3F50-6235-4424-BB58-745B44B2849B

Q33693852-2683B5E0-FCF9-44FE-81C8-0D6A678397CB

Q33693852-2B955400-B44C-400A-B2E0-6CB7554C286C

Q33693852-314A1C2B-532F-4659-9E5F-FFD75AE64CCC

Q33693852-35D0D4AA-2D88-4AC5-AEB9-72C2CAE7A99B

Q33693852-411C2C4D-E37D-4ECD-90C6-0FE69D694F12

Q33693852-67BF4A9E-6F3B-46A8-943D-DCC07B40DE60

Q33693852-6CBE47B0-9106-4257-98B2-F9557A3F563F

P304

Q33693852-F4318E03-4C71-4430-B396-5E92662A79F9

P31

Q33693852-1ED96438-BEBF-4C07-8A04-4ABCBAC99313

P407

Q33693852-A104ED26-2773-4ACD-ACBF-8151DADC2B61

P433

Q33693852-F8ECAE81-FC94-49FC-B2E4-E02C85CD957C

P478

Q33693852-BC2B84B3-713D-4C98-986F-E9953ED58919

P577

Q33693852-37156AC2-5EE6-4585-97C5-F3150C242327

P698

Q33693852-59B9645B-C263-4290-AFF5-F4A30448C774

P921

Q33693852-74FBD48D-88CD-4DC6-9BD1-739257BBC921

P932

Q33693852-DC6BBCD4-189F-41A0-9AA8-FE94A37E0B32

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.

@en

P2093

K A Eaton

http://www.w3.org/2001/XMLSchema#string

R D Leunk

http://www.w3.org/2001/XMLSchema#string

S Krakowka

http://www.w3.org/2001/XMLSchema#string

P2860

Association ofCampylobacter pylorion the Gastric Mucosa with Antral Gastritis in Children

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

Campylobacter pylori and gastroduodenal disease.

Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas.

Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia.

Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Helicobacter pylori and peptic ulcers: the present position.

Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori

Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.

Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole.

P304

1549-1554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9660981

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

105643

http://www.w3.org/2001/XMLSchema#string